Applied Nutrition - Director/PDMR Shareholding

Applied Nutrition

13/04/2026 16:47

RNS Number : 2629A

Applied Nutrition PLC

13 April 2026

 

Applied Nutrition plc

Director/PDMR Dealing

 

Applied Nutrition plc (the "Company"), a leading sports nutrition, health and wellness brand, announces the following transaction in the Company's shares. This announcement is made in accordance with Article 19(1) of the EU Market Abuse Regulation as incorporated into UK law through the European Union (Withdrawal) Act 2018.

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Marnie Millard
2
Reason for the notification
a)
Position/status
PDMR / Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Applied Nutrition plc
b)
LEI
213800KCP1IDX51ZHE47
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary shares of £0.0002 each
Identification code
GB00BPVDXX64
b)
Nature of the transaction
Purchase of shares
c)
Price(s) and volume(s)
Price
Volume
£2.249112
13,257
d)
Aggregated information
- Aggregated volume
n/a
- Price
e)
Date of the transaction
2026-04-13
f)
Place of the transaction
XOFF

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHSFMFIDEMSELL